(SSE:688399)
BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers specialized in infectious diseases ever since 2010. With headquarter located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi’an, Taizhou, Hainan and Yinchuan. Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations.
An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios
Over 800 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic
Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases
90 Countries within a year
Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.
10000 Machinery spots
Bioperfectus Nucleic Acid Extraction Solutions
were launched in over 10,000 laboratories
globally with a well-trained and quick-response
customer service team.